Belgrade, Republic of Serbia

Nada Dimitrijevic

This inventor holds 1 USPTO granted patent. Top assignee: American Biogenic Sciences, Inc.. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nada Dimitrijevic. Retrieved from https://idiyas.com/inventor/nada-dimitrijevic

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Nada Dimitrijevic

Introduction

Nada Dimitrijevic is a notable inventor based in Belgrade, YU. She has made significant contributions to the field of biomedicine, particularly in the development of methods for producing specific antibodies. Her work is characterized by a focus on fibrin-specific antibodies, which have important applications in medical research and treatment.

Latest Patents

Nada Dimitrijevic holds a patent for a method of producing fibrin-specific antibodies using soluble fibrin. The patent describes a method that utilizes a composition comprising soluble crosslinked DesAABB fibrin polymers and soluble non-crosslinked DesAABB fibrin polymers as immunogens. This innovative approach allows for the production of antibodies that specifically bind to these fibrin polymers while avoiding binding to various other fibrin-related substances.

Career Highlights

Nada is currently associated with American Biogenic Sciences, Inc., where she continues her research and development efforts. Her work has led to advancements in the understanding and application of fibrin-specific antibodies, which are crucial for various therapeutic interventions.

Collaborations

Throughout her career, Nada has collaborated with esteemed colleagues such as Paul E Gargan and David G Carville. These partnerships have enhanced her research and contributed to the successful development of her patented methods.

Conclusion

Nada Dimitrijevic's innovative work in producing fibrin-specific antibodies represents a significant advancement in biomedical research. Her contributions continue to impact the field positively, showcasing the importance of her inventions in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…